Andrew McAuley
Overview
Explore the profile of Andrew McAuley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
1033
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nicholls J, Masterton W, Falzon D, McAuley A, Carver H, Skivington K, et al.
Harm Reduct J
. 2025 Mar;
22(1):33.
PMID: 40089795
No abstract available.
2.
Nicholls J, Masterton W, Falzon D, McAuley A, Carver H, Skivington K, et al.
Harm Reduct J
. 2025 Jan;
22(1):6.
PMID: 39806415
Background: Scotland currently has amongst the highest rates of drug-related deaths in Europe, leading to increased advocacy for safer drug consumption facilities (SDCFs) to be piloted in the country. In...
3.
Fraser R, Yeung A, Glancy M, Hickman M, Jones H, Priyadarshi S, et al.
Addiction
. 2024 Oct;
120(2):276-284.
PMID: 39438020
Background And Aims: Opioid dependence is associated with an increased risk of suicide. Drug-related mortality among people with opioid dependence in Scotland has more than tripled since 2010; less is...
4.
Trayner K, Palmateer N, McAuley A, Yeung A, Cullen B, Wallace L, et al.
HIV Med
. 2024 Oct;
26(1):97-114.
PMID: 39367662
Background: In the context of an outbreak of HIV among people who inject drugs in Glasgow, Scotland, identified in 2015, our objectives were to: (1) develop epidemiological methods to estimate...
5.
Packer S, Patrzylas P, Merrick R, Sawyer C, McAuley A, Crowe W, et al.
Epidemiol Infect
. 2024 Oct;
152:e113.
PMID: 39355858
We aimed to estimate the secondary attack rate of mpox among UK household contacts and determine factors associated with transmission to inform public health management of contacts, during the global...
6.
Allen L, Fraser H, Stone J, McAuley A, Trayner K, Metcalfe R, et al.
J Infect Dis
. 2024 Jul;
230(1):e48-e59.
PMID: 39052745
Background: A human immunodeficiency virus (HIV) outbreak was identified among people who inject drugs (PWID) in Glasgow in 2015, with >150 diagnoses by the end of 2019. The outbreak response...
7.
Samartsidis P, Harris R, Dillon J, Desai M, Foster G, Gunson R, et al.
Int J Drug Policy
. 2024 Jun;
:104429.
PMID: 38942687
Background: There is limited empirical work assessing the effectiveness of treatment as prevention (TasP) in reducing HCV prevalence among people who inject drugs (PWID). Here, we used survey data from...
8.
Glancy M, Yeung A, McAuley A, Palmateer N, Bishop J, Taylor B, et al.
Clin Microbiol Infect
. 2024 Jun;
30(10):1312-1318.
PMID: 38936544
Objectives: Among people receiving opioid-agonist treatment (OAT), the risk of COVID-19 infection and disease may be higher owing to underlying health problems and vulnerable social circumstances. We aimed to determine...
9.
Glancy M, Palmateer N, Yeung A, Hickman M, Macleod J, Bishop J, et al.
Psychiatry Res
. 2024 Jun;
339:116028.
PMID: 38917674
Background: Prescribing of gabapentinoids and Z-drug-hypnotics has increased in the population and among people receiving opioid-agonist treatment (OAT) for opioid dependence. Evidence is mixed on whether co-prescribing of sedatives such...
10.
Macdonald C, Palmateer N, McAuley A, Lindsay L, Hasan T, Hameed S, et al.
NPJ Vaccines
. 2024 Jun;
9(1):107.
PMID: 38877008
Several population-level studies have described individual clinical risk factors associated with suboptimal antibody responses following COVID-19 vaccination, but none have examined multimorbidity. Others have shown that suboptimal post-vaccination responses offer...